HI
HIMS
HealthcareHims & Hers Health, Inc.
Drug Manufacturers - Specialty & Generic
Total Trades
5
Unique Traders
2
Purchases / Sales
4/1
News Articles
5
Trading History
| Date | Politician | Asset | Action | Amount | Trade Price | 30D Price | 1M Return | Alpha | 1M Prediction |
|---|---|---|---|---|---|---|---|---|---|
Feb 3, 2026 |  Tony WiedR | Stock | Buy | $50,001 - $100,000 | $25.54 | $15.88 | -37.8% | -36.6% | |
Dec 17, 2025 | Tony WiedR | Stock | Sell | $100,001 - $250,000 | $34.97 | $31.38 | -10.3% | -13.6% | |
Aug 4, 2025 |  Lisa McClainR | Stock | Buy | $1,001 - $15,000 | $63.35 | $44.46 | -29.8% | -31.8% | |
Feb 25, 2025 | Tony WiedR | Stock | Buy | $15,001 - $50,000 | $39.86 | $31.92 | -19.9% | -15.6% | |
Feb 24, 2025 | Tony WiedR | Stock | Buy | $100,001 - $250,000 | $51.31 | $33.36 | -35.0% | -30.5% |
Recent News
Regulatory Pressure Tests Novo Nordisk’s GLP 1 Moat And Valuation
Yahoo-Invalid Date
Novo Nordisk Tests Wegovy Patent Strength As Compounded Rivals Face Scrutiny
Yahoo-Invalid Date
Novo Nordisk opens new front with patent suit over Hims’ Wegovy copies
Yahoo-Invalid Date
As Hims & Hers Gets Hit With Major Wegovy Loss, Should You Buy the Dip in Deeply Oversold HIMS Stock?
Yahoo-Invalid Date
Hims & Hers says Novo Nordisk lawsuit ‘blatant attack’ on millions of Americans
Yahoo-Invalid Date